About Midway Pharmaceuticals Private Limited
Data last updated:
Midway Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 February 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2004PTC124433. Its GSTIN is 07AAECM0032H2ZX (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Mukesh Kumar Saini and Anil Kumar Saini.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No – 04 Office No – A – 116 Ist Floor R.G City Centre Motia Khan, Delhi, India – 110055.
As per the financials filed for FY 2023, the company reported a revenue of ₹4.28 Cr, a growth of 87% compared to the previous year. For the same year it recorded a net profit of ₹63,535 (net margin 0.1%) and EBITDA of ₹3.45 Lakh (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 34% over five years.
The company is associated with 1 brand: Midway Pharmaceuticals. As per MCA filings, the company has satisfied charges of ₹4.25 Cr on record. Court records list 13 cases involving the company, including 1 filed by the company and 12 filed against it; 6 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website midwaypharmaceutical.com.
Company details
Contact details
Midway Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is midwaypharmaceutical.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No – 04 Office No – A – 116 Ist Floor R.G City Centre Motia Khan, Delhi, India – 110055
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Midway Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Midway Pharmaceuticals operates one associated brand: Midway Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical marketing and exporting of medicines, medical devices, and essential oils from India. | midwaypharmaceutical.com |
Business activity
The main business activity of Midway Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Midway Pharmaceuticals Private Limited, buy the company report.
Financials of Midway Pharmaceuticals Private Limited
FY 2023 filings availableMidway Pharmaceuticals Private Limited reported revenue of ₹4.28 Cr (up 87% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 87% growth in the latest year. EBITDA rose 141% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.45 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹63,535 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Midway Pharmaceuticals Private Limited, buy the company report.
Board of directors of Midway Pharmaceuticals Private Limited
Midway Pharmaceuticals has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Kumar Saini Also directs: NMR Industries Limited, S.Satyam Aviations Private Limited | Director | 04 Feb 2004 | 22 Years 8 Months | Current |
| Anil Kumar Saini Also directs: NMR Industries Limited | Director | 02 Feb 2024 | 2 Years 8 Months | Current |
Peer comparison
Midway Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dhananjay Trexim Pvt Ltd | ₹4.29 Cr (FY 2025) | -21.0% | Kanpur, Uttar Pradesh, India | |||
| Connectlife Pharma Private Limited | ₹4.28 Cr (FY 2024) | -22.0% | New Delhi, Delhi, India | |||
| Midway Pharmaceuticals Private Limitedthis company | ₹4.28 Cr (FY 2023) | ₹63,535 | 0.1% | 87.0% | Delhi, India | |
| Bioves Pharmaceutical Private Limited | ₹4.28 Cr (FY 2025) | 10.0% | Hyderabad, Telangana, India | |||
| Remedial Healthcare India Private Limited | ₹4.27 Cr (FY 2024) | 16826133.0% | Ambala, Haryana, India | |||
| Alkans Pharmaceuticals Private Limited | ₹4.27 Cr (FY 2025) | 42.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Midway Pharmaceuticals Private Limited, buy the company report.
Auditor
Midway Pharmaceuticals Private Limited is audited by P A S ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P A S ASSOCIATES | FY 2020 | 514104C |
Shareholding
The shareholding of Midway Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Midway Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Oct 2011 | 10365554 | Oriental Bank of Commerce | ₹4.25 Cr | Satisfied |
To see the full charge records of Midway Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Midway Pharmaceuticals Private Limited has 13 court cases on record: 1 filed by Midway Pharmaceuticals, 12 filed against it. 6 cases are pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 12 | 6 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Magma Fincorp Limited | Pending |
| District court, North West, Delhi | Criminal case | Filed against the company by Ms Kotak Mahindra Bank Ltd | Disposed |
| District court, Central, Delhi | Execution petition | Filed against the company by Ecl Finance Ltd. | Disposed |
| District court, Central, Delhi | Execution petition | Filed against the company by Ms Tata Capital Financial Services Ltd. | Disposed |
| District court, North West, Delhi | Criminal case | Filed against the company by Magma Fincorp Ltd | Disposed |
To see the full case history of Midway Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Midway Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Midway Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECM0032H2ZX | Delhi | Active | 14 Mar 2018 |
To see the full GST registrations and return filing status of Midway Pharmaceuticals Private Limited, buy the company report.
Recent activity
Midway Pharmaceuticals Private Limited has 10 board changes on record since 2004: 2 appointments and 8 cessations. The latest: Anil Kumar Saini was appointed as Director on 02 Feb 2024.
4 earlier events are in the company report.
Frequently asked questions
Midway Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 February 2004 (22+ years old) and is registered under CIN U24239DL2004PTC124433.
Midway Pharmaceuticals has 2 current directors:
- Mukesh Kumar Saini - Director
- Anil Kumar Saini - Director
The latest financial statements of Midway Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Midway Pharmaceuticals is 07AAECM0032H2ZX, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Midway Pharmaceuticals is U24239DL2004PTC124433. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Midway Pharmaceuticals has 13 court cases on record: 1 filed by the company and 12 filed against it. 6 are pending.
Midway Pharmaceuticals was incorporated on 04 February 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Midway Pharmaceuticals by revenue are Dhananjay Trexim Pvt Ltd, Connectlife Pharma Private Limited, Bioves Pharmaceutical Private Limited, Remedial Healthcare India Private Limited, Alkans Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Anil Kumar Saini was appointed as Director on 02 Feb 2024. Raj Singh ceased to be Director on 20 May 2020. Narendra Kumar Saini ceased to be Additional Director on 30 Sep 2019. Midway Pharmaceuticals has 10 board changes on record in total.
Midway Pharmaceuticals can be reached through the website midwaypharmaceutical.com. Its registered office is in Delhi, India.
The registered office of Midway Pharmaceuticals is at Plot No – 04 Office No – A – 116 Ist Floor R.G City Centre Motia Khan, Delhi, India – 110055.